CCL13 and human diseases

47Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many immune cells. Despite extensive research into its function in numerous disorders, a thorough analysis of CCL13 is not yet accessible. The role of CCL13 in human disorders and existing CCL13-focused therapies are outlined in this study. The function of CCL13 in rheumatic diseases, skin conditions, and cancer is comparatively well-established, and some studies also suggest that it may be involved in ocular disorders, orthopedic conditions, nasal polyps, and obesity. We also give an overview of research that found very little evidence of CCL13 in HIV, nephritis, and multiple sclerosis. Even though CCL13-mediated inflammation is frequently linked to disease pathogenesis, it’s fascinating to note that in some conditions, like primary biliary cholangitis (PBC) and suicide, it might even act as a preventative measure.

Cite

CITATION STYLE

APA

Li, L., Dai, F., Wang, L., Sun, Y., Mei, L., Ran, Y., & Ye, F. (2023). CCL13 and human diseases. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2023.1176639

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free